A multicenter phase II trial of pre-operative chemotherapy with Gemcitabine/ Cisplatin /S-1 for biliary tract cancers with lymph node metastasis diagnosed by FDG-PET

Trial Profile

A multicenter phase II trial of pre-operative chemotherapy with Gemcitabine/ Cisplatin /S-1 for biliary tract cancers with lymph node metastasis diagnosed by FDG-PET

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Cisplatin (Primary) ; Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
  • Indications Biliary cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Feb 2017.
    • 28 Mar 2013 Planned end date changed to 1 Feb 2019 as reported by ClinicalTrials.gov record.
    • 28 Mar 2013 New source identified and integrated (ClinicalTrials.gov; NCT01821248).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top